Literature DB >> 18173285

Syntheses and biological activity of amamistatin B and analogs.

Kelley A Fennell1, Ute Möllmann, Marvin J Miller.   

Abstract

Amamistatins A and B, natural products isolated from a strain of Nocardia, showed growth inhibition against three human tumor cell lines (IC(50) 0.24-0.56 microM). Structurally related mycobactins affect the growth of both mycobacterial and human cells through interference with iron chelation. To further probe the biological activity of this class of compounds, the total syntheses of amamistatin B and two analogs were completed, and the synthetic samples were screened for tumor cell growth inhibition, HDAC inhibition, and Mycobacterium tuberculosis growth inhibition. Amamistatin B (15) and diastereomer 18 were both active against MCF-7 cells (IC(50) 0.12-0.20 microM), and less so against PC-3 cells (IC(50) 8-13 microM). Amamistatin B only moderately inhibited the growth of M. tuberculosis (MIC 47 microM) but showed growth promotion of Mycobacterium smegmatis and other bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18173285     DOI: 10.1021/jo7020532

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  13 in total

1.  A new approach to cyclic hydroxamic acids: Intramolecular cyclization of N-benzyloxy carbamates with carbon nucleophiles.

Authors:  Yuan Liu; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron       Date:  2011-03-25       Impact factor: 2.457

2.  Syntheses and studies of amamistatin B analogs reveals that anticancer activity is relatively independent of stereochemistry, ester or amide linkage and select replacement of one of the metal chelating groups.

Authors:  Chunrui Wu; Patricia A Miller; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2011-01-22       Impact factor: 2.823

3.  Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster.

Authors:  Sivagami Sundaram Chavadi; Karen L Stirrett; Uthamaphani R Edupuganti; Olivia Vergnolle; Gigani Sadhanandan; Emily Marchiano; Che Martin; Wei-Gang Qiu; Clifford E Soll; Luis E N Quadri
Journal:  J Bacteriol       Date:  2011-08-26       Impact factor: 3.490

4.  Total synthesis and biological evaluation of transvalencin Z.

Authors:  Kathryn M Nelson; Christine E Salomon; Courtney C Aldrich
Journal:  J Nat Prod       Date:  2012-05-22       Impact factor: 4.050

5.  Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis.

Authors:  Raúl E Juárez-Hernández; Scott G Franzblau; Marvin J Miller
Journal:  Org Biomol Chem       Date:  2012-08-16       Impact factor: 3.876

6.  Syntheses of new spirocarbocyclic nucleoside analogs using iminonitroso Diels-Alder reactions.

Authors:  Weimin Lin; Anuradha Gupta; Kyung Hee Kim; David Mendel; Marvin J Miller
Journal:  Org Lett       Date:  2009-01-15       Impact factor: 6.005

7.  Computational exploration of zinc binding groups for HDAC inhibition.

Authors:  Kai Chen; Liping Xu; Olaf Wiest
Journal:  J Org Chem       Date:  2013-04-29       Impact factor: 4.354

Review 8.  Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents.

Authors:  Marvin J Miller; Helen Zhu; Yanping Xu; Chunrui Wu; Andrew J Walz; Anne Vergne; John M Roosenberg; Garrett Moraski; Albert A Minnick; Julia McKee-Dolence; Jingdan Hu; Kelley Fennell; E Kurt Dolence; Li Dong; Scott Franzblau; Francois Malouin; Ute Möllmann
Journal:  Biometals       Date:  2009-01-07       Impact factor: 2.949

9.  Metabolically programmed iron chelators.

Authors:  Raymond J Bergeron; Neelam Bharti; James S McManis; Jan Wiegand
Journal:  Bioorg Med Chem       Date:  2015-06-29       Impact factor: 3.641

Review 10.  Design and Syntheses of New Antibiotics Inspired by Nature's Quest for Iron in an Oxidative Climate.

Authors:  Marvin J Miller; Rui Liu
Journal:  Acc Chem Res       Date:  2021-03-08       Impact factor: 24.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.